Summary: Researchers have developed a safe, noninvasive, and painless method to enhance the sense of smell using radiofrequency waves. Instead of relying on strong odorants or medications, this approach stimulates olfactory nerves directly with a small antenna positioned near the forehead, producing measurable improvements in smell sensitivity.
In controlled testing, a single five-minute session increased participants’ ability to detect faint odors for more than a week. The technique could offer a new therapeutic option for people with olfactory disorders and a tool to sharpen scent perception for professionals who depend on precise aroma discrimination.
Key Facts
- Noninvasive Therapy: Radiofrequency stimulation enhances smell without chemicals, drugs, or surgery.
- Documented Effect: One five-minute treatment improved odor detection for over a week in healthy volunteers.
- Potential Applications: Promising for patients with smell loss and for professionals such as perfumers, chefs, and tasters.
Source: American Institute of Physics
Smell plays a central role in daily life: it enriches flavor, warns us of hazards like smoke or gas, and links strongly to memory and emotion. Yet many people experience reduced or lost smell (hyposmia or anosmia) due to causes such as viral infection, aging, or head injury. Current therapies are limited and often rely on repetitive exposure to strong scents or medications that can be uncomfortable or only partially effective.
A new study published in APL Bioengineering by researchers at Hanyang University and Kwangwoon University in South Korea reports a different strategy: noncontact radiofrequency (RF) stimulation targeted at the olfactory nerve. Unlike traditional olfactory training that uses odorants to indirectly stimulate smell pathways, RF stimulation aims to activate the neural structures responsible for smell directly, without tissue contact or chemical exposure.
“The method is completely noninvasive — no surgery or chemicals needed — and safe, as it does not overheat the skin or cause discomfort,” said lead author Yonwoong Jang. The device uses a compact antenna placed near, but not touching, the forehead to emit controlled radio waves that reach olfactory nerve regions located deep in the skull.
In the study, healthy volunteers sat quietly while a small RF antenna was positioned close to their forehead for five minutes. Researchers measured smell sensitivity before and after stimulation using standardized odor threshold tests with pen-shaped odor dispensers (Sniffin’ Sticks) that present weak concentrations of odorants such as diluted n-butanol and familiar scents like grapes and bananas. Simultaneously, they recorded electrophysiological responses to confirm increased activity in olfactory nerves.
Results showed a significant improvement in odor detection thresholds after a single 5-minute RF session. Across subjects, the average n-butanol threshold score rose from 9.73 ± 2.45 to 15.88 ± 0.25 following stimulation at 10–20 W, with enhanced sensitivity persisting for up to one week. Electrobulbogram recordings supported these behavioral findings by showing a clear increase in electrical signals from olfactory nerves after stimulation.
Compared with chemical-based olfactory training, RF stimulation offers several advantages: it avoids the discomfort that some patients experience with strong odorants, reduces the risk of habituation or dissipation of effects, and provides sustained neural activation without direct physical contact. These attributes make RF stimulation a promising candidate for clinical development as a therapeutic option for olfactory dysfunction.
The initial trial focused on individuals with normal smell function to evaluate safety and basic efficacy. The researchers plan follow-up studies to test the method in people with olfactory impairment, including anosmia and hyposmia. Those trials will be critical to determine whether RF stimulation can restore or significantly improve smell in patients who need treatment most.
Beyond clinical therapy, RF olfactory stimulation may have applications for professionals who rely on high-level scent discrimination—such as perfumers, culinary experts, and quality-control specialists—by preserving or briefly enhancing odor sensitivity for critical evaluations.
About this olfaction and neurotech research news
Author: Hannah Daniel
Source: American Institute of Physics
Contact: Hannah Daniel – American Institute of Physics
Image: The image is credited to Neuroscience News
Original Research: Open access. “Noncontact radiofrequency stimulation to the olfactory nerve of human subjects” by Yonwoong Jang et al., APL Bioengineering.
Abstract
Noncontact radiofrequency stimulation to the olfactory nerve of human subjects
Damage to the olfactory nerve from aging, trauma, or neurological conditions can cause smell loss, diminishing quality of life, reducing taste perception, and affecting safety and emotional well-being. Current standard care often involves olfactory training with aromatic odorants, which offers incremental benefit but does not directly restore neural activity.
This study explores RF stimulation as a direct means to activate olfactory nerves. Using 3D modeling to verify specific absorption rates, investigators positioned an RF antenna near the forehead and measured odor sensitivity with n-butanol threshold tests and responses to natural odors in 28 healthy subjects. Electrobulbogram recordings confirmed increased olfactory nerve activity after stimulation.
In the primary cohort of 23 subjects, the mean odor threshold for n-butanol improved from 9.73 ± 2.45 to 15.88 ± 0.25 after a single 5-minute RF exposure at 10–20 W, with effects lasting up to one week. Electrophysiological measures and responses to familiar odors like grapes and bananas also showed enhanced signaling post-stimulation. Unlike chemical therapies, RF stimulation produced sustained nerve activation without causing discomfort.
These findings support the potential of radiofrequency technology for olfactory training and as a novel treatment approach for olfactory dysfunction, as well as for maintaining or temporarily enhancing odor sensitivity in professional settings. Further clinical trials in patients with documented smell loss will be essential to validate therapeutic benefit and guide clinical adoption.